TAMPA, FL--(Marketwire - March 25, 2009) - Transfer Technology International (PINKSHEETS: TTIN), an emerging technology transfer company, announced today the initial laboratory test results for its organic canker control formulation.
Initial independent lab testing indicates that Transfer Technology International’s organic canker control formula provided a significantly greater reduction of bacteria that causes citrus canker than the most widely used copper based treatment. APL Sciences reports that Transfer Technology International’s environment friendly, biodegradable formula proved significantly more effective than the most popular citrus canker suppression product. In a controlled laboratory environment, within five minutes after application, the organic canker control formulation indicated a 100% eradication of bacteria that causes citrus canker.
Chris Trina, Chairman and CEO, states, “The test results speak for themselves. 100% eradication of the canker organisms is incredible news for citrus growers. Our non-toxic, environment friendly, biodegradable formula was much more effective than the competitors’ copper based product. We will move forward at warp speed with additional lab testing, greenhouse testing and field testing to bring this product to market as soon as possible. We are well on our way to bringing more effective, socially responsible products to the marketplace. While our initial target for this particular product is the $8 billion Florida citrus industry, we believe there are many other applications that will bring additional revenues to Transfer Technology International.”
About Transfer Technology International Corp. (PINKSHEETS: TTIN)
Our company was formed to support research, development, and commercialization of cutting edge, socially responsible technologies. Product commercialization, technology transfer, and market penetration will provide the basis for superior financial returns.
Please visit our website, www.ttinternationalcorp.com for more information.
Disclaimer and Forward-Looking Statements -- The information contained herein regarding risks and uncertainties, which may differ materially from those set forth in these statements, in addition to the economic, competitive, governmental, technological and other factors, constitutes a “forward-looking statement” within the meaning of Section 27A of The Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbors created thereby. While the company believes that the assumptions underlying such forward-looking information are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking information will prove to be accurate. Accordingly, there may be differences between the actual results and the predicted results, and actual results may be materially higher or lower than those indicated in the forward-looking information contained herein.
Contact:
Mr. Christoph Trina
Chairman and CEO
(813) 600-4081
Scientific Data Inquiries:
LeeAnn Applewhite
(352) 376-9762